In Vitro Antifungal Efficacy of Blue-Light Photodynamic Therapy with Curcumin and Riboflavin Formulation Activated by 450 nm Diode Laser Against <i>Candida albicans</i> Biofilm on Titanium Implants.

Pharmaceutics · 2025 · PMC12655314 · PMID 41304775

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the L + QBX group achieved the highest mean CFU/mL reduction (94.3%), this improvement did not reach statistical significance compared to L + CUR or L + RIB.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

In Vitro Antifungal Efficacy of Blue-Light Photodynamic Therapy with Curcumin and Riboflavin Formulation Activated by 450 nm Diode Laser Against &lt;i&gt;Candida albicans&lt;/i&gt; Biofilm on Titanium Implants.

The sentences

In Vitro Antifungal Efficacy of Blue-Light Photodynamic Therapy with Curcumin and Riboflavin Formulation Activated by 450 nm Diode Laser Against <i>Candida albicans</i> Biofilm on Titanium Implants.